Cambrex Corp (NYSE:CBM)

CAPS Rating: 4 out of 5

A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.

Recs

1
Player Avatar CycleFreak7 (< 20) Submitted: 2/23/2007 9:20:00 AM : Outperform Start Price: $10.63 CBM Score: +59.99

Reading EPS100Momentum's blog led me to CBM and the news of the company's intent to distribute a large dividend of $13.50 - $14.50 at an unspecified date in the future.

After watching SMG on the news of it's special one-time $8 dividend, there can be little doubt that CBM will appreciate considerably as the record date for the dividend approachs.

Featured Broker Partners


Advertisement